CDKN2B and metabolic syndrome: It is worth noting that the strengths of the present study lie in investigating the association of specific genetic polymorphisms in IKZF3, LET7‐a2, and CDKN2B‐AS1, with MetS pathogenesis under different genetic models in a large sample size for the first time.